AC
IONS icon

AXQ Capital’s Ionis Pharmaceuticals IONS Stock Holding History

AXQ Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
+3,846
New +$304K 0.04% 612
2025
Q2 		– Sell
-30,104
Closed -$908K – 665
2025
Q1 		$908K Buy
+30,104
New +$986K 0.36% 70

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AXQ Capital's IONS Position: Q1 2026 in Review

AXQ Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 3,846 shares worth $289K. The stake represents 0.04% of the portfolio and ranks #612 among its holdings. This is a return to the name: AXQ Capital previously reported a position in IONS as recently as Q1 2025.

AXQ Capital first reported a position in IONS in Q1 2025 and has held it in 2 quarters since. The position peaked at $908K in Q1 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • AXQ Capital held 3,846 shares of Ionis Pharmaceuticals worth $289K as of Q1 2026.
  • Ionis Pharmaceuticals was a new AXQ Capital position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.04% of AXQ Capital's portfolio in Q1 2026, its #612 holding.
  • AXQ Capital first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • AXQ Capital's Ionis Pharmaceuticals position peaked at $908K in Q1 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.